» Articles » PMID: 35433340

Renal Biopsy Reports in Nephritic Syndrome: Update

Overview
Journal World J Nephrol
Specialty Nephrology
Date 2022 Apr 18
PMID 35433340
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Nephritic syndrome (NiS) is a major indicator of serious renal diseases necessitating kidney biopsies for histopathological evaluations, but due to the lack of comprehensive reviews in the literature, the current understanding of the syndrome and its significance is limited.

Aim: To collect all the evidence retrievable from the literature on the diagnoses made on the renal biopsies performed for NiS as the indication to the procedure.

Methods: A literature search was conducted to find studies reporting final diagnoses on renal biopsies in NiS patients. Data were pooled and analyzed with stratifications on age and regions. Meta-analyzes were performed using Stata v.9.

Results: Overall, 26414 NiS patients from the total number of 96738 kidney biopsy diagnoses reported by 47 studies from 23 countries from all continents (except sub-Saharan Africa) were found and analyzed. NiS was the indication for renal biopsy in 21% of the patient populations across the reviewed studies. Immunoglobulin A (IgA) nephropathy was the single most frequent diagnosis in these patients (approximately 38%) followed by lupus nephritis (approximately 8%) and Henoch Schönlein purpura (approximately 7%). IgA nephropathy was the most frequent diagnosis reported for the NiS patients from the East Asia, comprising half of all the cases, and least prevalent in South Asia. Considering the age subgroups, adult ( pediatric or elderly) patients were by far the most likely age group to be diagnosed with the IgA nephropathy. A myriad of such regional and age disparities have been found and reported.

Conclusion: As the indication for renal biopsy, NiS represents a very distinctive epidemiology of final renal disease diagnoses compared to the other major syndromes.

Citing Articles

Moshen granule ameliorates membranous nephropathy by regulating NF-ƙB/Nrf2 pathways via aryl hydrocarbon receptor signalling.

Ma S, Li X, Duan T, Pei M, Zou L, Yu X Heliyon. 2023; 9(9):e20019.

PMID: 37809643 PMC: 10559749. DOI: 10.1016/j.heliyon.2023.e20019.


Serum levels of galactose-deficient IgA are elevated in patients with IgA nephropathy but do not correlate to disease activity or progression.

Eliasdottir S, Khramova A, Saeed A, Guron G, Boi R, Molne J BMC Nephrol. 2023; 24(1):160.

PMID: 37286948 PMC: 10245488. DOI: 10.1186/s12882-023-03198-y.

References
1.
Chiu H, Chen H, Lu K, Shu K . Distribution of glomerular diseases in Taiwan: preliminary report of National Renal Biopsy Registry-publication on behalf of Taiwan Society of Nephrology. BMC Nephrol. 2018; 19(1):6. PMC: 5764016. DOI: 10.1186/s12882-017-0810-4. View

2.
Nair R, Bell J, Walker P . Renal biopsy in patients aged 80 years and older. Am J Kidney Dis. 2004; 44(4):618-26. View

3.
AlYousef A, AlSahow A, AlHelal B, AlQallaf A, Abdallah E, Abdellatif M . Glomerulonephritis Histopathological Pattern Change. BMC Nephrol. 2020; 21(1):186. PMC: 7236312. DOI: 10.1186/s12882-020-01836-3. View

4.
Costa D, Valente L, Gouveia P, Sarinho F, Vajgel Fernandes G, Cavalcante M . Comparative analysis of primary and secondary glomerulopathies in the northeast of Brazil: data from the Pernambuco Registry of Glomerulopathies - REPEG. J Bras Nefrol. 2017; 39(1):29-35. DOI: 10.5935/0101-2800.20170005. View

5.
Hu R, Quan S, Wang Y, Zhou Y, Zhang Y, Liu L . Spectrum of biopsy proven renal diseases in Central China: a 10-year retrospective study based on 34,630 cases. Sci Rep. 2020; 10(1):10994. PMC: 7335090. DOI: 10.1038/s41598-020-67910-w. View